Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.03.9923.1222
Address
Level 10 99 Queen Street Melbourne, Victoria (VIC) 3000
Description
Opyl Ltd. is an information technology company, which engages in the development of digital tools that improve the healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of clinical research process. Its services Opin-Clinical Trial Recuitment platform created by Opyl that leverages social media, search engine optimization technologies, and emerging artificial intelligence science, matching patients directly to clinical trials. The company was founded by Marc Angelone and Noah Abelson-Gertleron on January 17, 1994 and is headquartered in St. Kilda, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.05
Trade Value (12mth)
AU$1,189.00
1 week
6.25%
1 month
-32%
YTD
-41.38%
1 year
-64.55%
All time high
125919.00
EPS 3 yr Growth
-35.30%
EBITDA Margin
-805.00%
Operating Cashflow
-$2m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-7.50
Quick Ratio
0.80
Shares on Issue (Fully Dilluted)
171m
HALO Sector
Technology
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
05 September 24 |
Company Secretary Appointment/Resignation
×
Company Secretary Appointment/Resignation |
02 September 24 |
Resignation of Mr Mark Simari
×
Resignation of Mr Mark Simari |
02 September 24 |
Final Director's Interest Notice - M Simari
×
Final Director's Interest Notice - M Simari |
30 August 24 |
Change to Webinar Date
×
Change to Webinar Date |
29 August 24 |
Opyl - Appendix 4E
×
Opyl - Appendix 4E |
29 August 24 |
Opyl - Full Year Results
×
Opyl - Full Year Results |
29 August 24 |
Opyl 2024 Annual Report
×
Opyl 2024 Annual Report |
29 August 24 |
Opyl - Appendix 4G
×
Opyl - Appendix 4G |
29 August 24 |
Opyl - Corporate Governance Statement
×
Opyl - Corporate Governance Statement |
22 August 24 |
Opyl Secures $700K loans to advance TrialKey & Drive Growth
×
Opyl Secures $700K loans to advance TrialKey & Drive Growth |
02 August 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
02 August 24 |
Change in substantial holding
×
Change in substantial holding |
31 July 24 |
Opyl - Business Update & Appendix 4C
×
Opyl - Business Update & Appendix 4C |
29 July 24 |
Notification of cessation of securities - OPL
×
Notification of cessation of securities - OPL |
24 July 24 |
OPL signs MOU for EMEA & US Expansion
×
OPL signs MOU for EMEA & US Expansion |
11 July 24 |
Change of Director's Interest Notice - D Rasheed
×
Change of Director's Interest Notice - D Rasheed |
08 July 24 |
Opyl Partners with L39 Capital to Launch AI Biotech Fund
×
Opyl Partners with L39 Capital to Launch AI Biotech Fund |
17 June 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
17 June 24 |
Change in substantial holding
×
Change in substantial holding |
14 June 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
14 June 24 |
Change in substantial holding
×
Change in substantial holding |
06 June 24 |
Opyl Announces First Trial Gen Revenue & Customer
×
Opyl Announces First Trial Gen Revenue & Customer |
05 June 24 |
Change of Director's Interest Notice - D Rasheed
×
Change of Director's Interest Notice - D Rasheed |
05 June 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
05 June 24 |
Change in substantial holding
×
Change in substantial holding |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.